Trade IPOs with Eva: June 2014

Thursday, June 26, 2014

Crafts retailer Michaels raises $473 million in IPO

(Reuters) - Michaels (MIK) said on Thursday it had raised about $472.6 million in its initial public offering after pricing shares at $17, the lower end of an expected range.

The $17 per share price values the arts and crafts retailer at up to $3.45 billion.

Michaels' IPO said it had sold all 27.8 million shares on offer, as it priced at the lower end of the expected range of $17-$19 per share.

Michaels, which owns several private brands such as Recollections, Artist's Loft and Loops & Threads, competes with Hobby Lobby Stores Inc, Jo-Ann Stores Inc and Wal-Mart Stores Inc (WMT.N).

Michaels, the largest arts and crafts specialty retailer in North America, sells scrapbooking and papercraft supplies, apparel and framing accessories, kids clothing, home and ceremony decor.

The retailer, with more than 1,200 stores and about $4.6 billion in sales in fiscal 2013, also offers customized invitation cards and courses in baking, and beading and jewelry making.

Michaels reported a rise of 9 percent in net sales to $4.57 billion between 2011-2013. Net income rose 55 percent to $243 million during the same period.

Michaels, which was taken private by Blackstone Group LP and Bain Capital LP for $6 billion in 2006, filed for an IPO of up to $500 million in March 2012.

That, however, was postponed after then-Chief Executive John Menzer had a stroke and stepped down.

Bain Capital and Blackstone Group currently own 93 percent of the company as Michaels Holdings LLC, which was formed following the reorganization of Michaels into a holding company structure in July 2013.

The two private equity firms will own about 80 percent of the company after the IPO, if underwriters do not exercise their option.

Michaels said in April it was hit by a security breach of customer payment cards and about 400,000 cards were potentially affected by the breach, which occurred between June 26, 2013, and February 27, 2014.

Michaels, which has about $3.7 billion in debt as of May, said it plans to use the proceeds from the offering to redeem $466 million of Holdco notes, issued in July 2013.

The company is expected to debut on the Nasdaq on Friday under the symbol "MIK".

J.P. Morgan and Goldman Sachs were lead underwriters to the offering.

GoPro (GPRO) began trading on the NASDAQ on 26 June 2014

Nick Woodman takes a GoPro selfie with BeckyQuick of SquawkCNBC

CBS Outdoor Americas (CBSO) : 3-month performance

IMS Health Holdings (IMS) began trading on the NYSE on 4 April 2014

IMS Health Holdings, Inc. provides information, services, and technology to the healthcare industry worldwide. The company develops healthcare measurement solutions, such as IMS LifeLink program that provides data sourced from longitudinal prescriptions, medical claims, and electronic medical records; IMS NPA Market Dynamics, a national prescription audit program; IMS Xponent Prescribing Dynamics, a solution that allows clients to segment and identify physicians, refine messages, adapt and change tactics, and align sales compensation metrics; IMS PlanTrak Market Dynamics, which integrates with patient-level data providing payer and plan level visibility within key performance indicators separating new, switch, and repeat prescriptions; and Specialty Market Dynamics that integrates patient-level data from specialty pharmacy providers, retail pharmacies, and mail service suppliers to help clients in measuring, monitoring, and benchmarking specialty market performance. The company also provides consumer health insights, forecasting solutions, payer insights, pharmaceutical measurement solutions, and publications. In addition, it offers healthcare analytics and services that include specialty healthcare analytics, pharmaceutical R and D services, government solutions, business process outsourcing solutions, patient-centric solutions, pharmaceutical commercial services, and payer solutions; and consulting services. The company also serves pharmaceutical, payers, government, providers, pharmacies, consumer health, pharmaceutical distribution, and financial community sectors. IMS Health Incorporated has a strategic alliance with BroadReach Healthcare. The company was formerly known as Healthcare Technology Holdings, Inc. and changed its name to IMS Health Holdings, Inc. in December 2013. The company was founded in 1954 and is based in Danbury, Connecticut. The company is a former subsidiary of Nielsen Media Research, Inc.

Address

83 Wooster Heights Road
DANBURY, CT 06810
United States

Website

http://www.imshealth.com

Key stats and ratios

	Q1 (Mar '14)	2013
Net profit margin	-3.72%	3.22%
Operating margin	10.39%	13.92%
EBITD margin	-	30.03%
Return on average assets	-1.21%	1.01%
Return on average equity	-10.78%	6.39%
Employees	9,500

Aerie Pharmaceuticals (AERI) : 8-month performance

Wednesday, June 25, 2014

Sports-selfie camera sensation GoPro’s IPO prices at top of range

GoPro, the maker of wearable cameras beloved of extreme sports enthusiasts, has also found fans in the stock market. The company priced its initial public offering at $24, the top of the indicated range of $21 to $24 amid strong demand.
GoPro raises $425 million in IPO
IPO values GoPro at nearly $3bn

GoPro priced shares at $24 apiece, the high end of the expected range of $21 to $24. The consumer electronics company's IPO raise is set to raise roughly $425 million.

The IPO sets the stage for GoPro to kick off its life as a public company on Thursday on the Nasdaq under the ticker symbol "GPRO."

debuting his first camera--the GoPro 35mm Hero--in September 2004 at San Diego's Action Sports Retailer trade show.

Nicholas "Nick" Woodman, founder and chief executive officer of GoPro, wears a camera as he throws out the first pitch in San Diego.

Last year, GoPro sold more than 13.5 million HD cameras in more than 100 countries and in 25,000 retail stores, the company said.

David Menlow, president of IPOfinancial.com, said GoPro is clearly a "hot brand" that is "on fire" thanks to the popularity of its durable product.

A successful viral marketing campaign has amplified GoPro's visibility and cemented its extreme brand credentials.

One video shot on the company's HERO3 camera features incredible images from around the world and has generated 32 million views on YouTube over the past year. In 2012, Felix Baumgartner wore a GoPro camera to give the world a first-person view of his space jump from 24 miles above the earth's surface.

GoPro's HERO cameras represented a 45% share of the U.S. camcorder market by dollars in 2013, up from 11% in December 2011, according to statistics from The NPD Group cited in the company's IPO filing.

Kite Pharma (KITE) began trading on the NASDAQ on 20 June 2014

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. The Company does this using its engineered autologous cell therapy (eACT). eACT involves the genetic engineering of T cells to express either chimeric antigen receptors (CARs, or T cell receptors, or TCRs). These modified T cells are designed to recognize and destroy cancer cells. The Company funds multiple Phase I-2a clinical trials with CAR- and TCR-based therapies that are being conducted by its collaborator, the Surgery Branch of the National Cancer Institute (NCI). The Company plans to conduct a Phase I-2 clinical trial for its lead product candidate KTE-C19, a CAR-based therapy, in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL).